Colby T. Ford, Ph.D.·Oct 26Evaluating AI-Generated Protein Binders with Microsoft’s BioEmu2 ModelEarlier this week, the Microsoft Research AI team released an update to their BioEmu model (called BioEmu2), which enables molecular…
Dhruv Ghulati·Oct 14Venturing into AI for bio — a journeyMy background is in payments, compliance, media monitoring, and AI. In 2023, I was introduced to a company called Cradle, which provides…
Ysunita·Sep 11Can AI Design a New Drug From Scratch?Originally published in longer form, with full sourcing and an FAQ, on my Substack
Nicholas Mitsakos·Aug 3AI is Not a Magic BulletAI is a powerful tool, but we barely understand human biology. A powerful weapon pointed randomly hits nothing.A response icon1A response icon1
Engin Yapici·Feb 3I Went Through BindCraft’s Affinity Data. Here Are the Gaps I Found.65 binders from 212 designs. Only 20 have KD measurements.
BiopharmaHUB·Jan 21Generative AI Approach for De Novo Molecule Design: The Tech, The Frontiers and The Challenges.Drug discovery has always been constrained by the fundamental challenge of an astronomically large chemical space.
InLow Code for Data Sciencebyzipengz·Aug 11, 2025Machine Learning for Pharmacological Activity Prediction in KNIMECodeless machine learning workflow to assess pharmacological activity
InLow Code for Data SciencebyCarlos Daniel Ramírez Márquez·May 30, 2025Exploring Chemical Databases with KNIMELow-code workflows for cheminformatics
Nexco Analytics·Nov 15, 2024Harnessing Bioinformatics to Accelerate RNA-Targeting TherapeuticsChallenges, Opportunities, and RNA Bioinformatics at Nexco
InAIRI.InstitutebyAIRI Team·Oct 11, 2024Researchers improved a reinforcement learning-based model for drug discoveryMedications have intrigued people since ancient times. Since then, pharmacology has evolved into a full-fledged science. However, despite…
